Looks like the directors are getting a bit anxious. Trying their best to boost the share price prior to their 5.4million incentive options expiring on 30 June 2008 ($1.00 exercise price).
I suspect they felt that assay results may only come in after 30 June 08 so they released "Preliminary analysis of the massive sulphides using a Niton portable XRF analyser (see disclaimer)" instead.
Although i'm a shareholder, I really hope the share price stays below $1.00 until after the options expire because the directors are already clearly overpaid and don't deserve any rewards for their performance to date.
Add to My Watchlist
What is My Watchlist?